Comparision of two drugs in nerve block for patients undergoing upper limb surgeries.

A comparative study between Clonidine and Dexamethasone as an adjuvant to 0.5% Bupivacaine in supraclavicular brachial plexus block.

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030400

Enrollment

Registered

2021-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK: TWO DRUGS(CLONIDINE 50 micrograms AND DEXAMETHASONE 4 milligram)WILL BE ADDED TO LOCAL ANAESTHETIC (0.5% BUPIVACAINE 20 milliliter) IN SUPRACLAVI

Eligibility

Inclusion criteria

Inclusion criteria: Patients with American society of anaesthesiologists (ASA) physical status I and II undergoing upper limb surgeries under brachial plexus block.

Exclusion criteria

Exclusion criteria: 1.Infection at the injection site. 2.Presence of coagulopathies. 3.Known and tested hypersensitivity to Bupivacaine, Clonidine and Dexamethasone drugs. 4.Pregnancy.

Design outcomes

Primary

Measure	Time frame
The primary outcome measure in this study is the onset of sensory and motor block at baselineTimepoint: The primary outcome measure in this study is the onset of sensory and motor block at baseline	—

Secondary

Measure	Time frame
The secondary outcome measure in the study is the duration of sensory and motor block.Timepoint: 1.5 years	—

Countries

India

Contacts

Public ContactKATYPALLY NAVEENA

KALINGA INSTITUTE OF MEDICAL SCIENCES

tapankumarray.ray@gmail.com9861046212

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026